Primary Care Medicine: On Demand 5.1
|
$399.20
Use promo code (Limited Offer)
15 CREDITS
  Hurry! Offer expires January 1, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (64 minutes) | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Clinician Need to Know? | K. Cusi, MD |
| Session 2 (52 minutes) | Updates in Cardiometabolic Therapies: Embracing Opportunities to Improve Care and Outcomes | N. Desai, MD |
| Session 3 (73 minutes) | Optimizing the Management of Hyperlipidemia: A Case Based Approach | N. Desai, MD |
| Session 4 (64 minutes) | Practical Approaches to Prescribing Weight-Loss Medications in the Patient with Obesity | D. Horn, MD |
| Session 5 (59 minutes) | Atrial Fibrillation | S. Kaatz, Do |
| Session 6 (53 minutes) | An Updated Toolbox for the Preventive and Abortive Treatment of Migraine | D. Kuruvilla, MD |
| Session 7 (62 minutes) | The Use of Integrative Therapies in Headache Care – Fact or Fiction | D. Kuruvilla, MD |
| Session 8 (57 minutes) | Male Hypogonadism: Update | K. Pantalone, DO |
| Session 9 (119 minutes) | Office Orthopedics in Primary Care | J. Post, MD |
| Session 10 (67 minutes) | Inflammatory Bowel Disease Primer | A. Stein, MD |
| Session 11 (64 minutes) | COPD 2020 Update | C. Strange, MD |
| Session 12 (54 minutes) | Drug Safety in Chronic Kidney Disease | M. Weir, MD |
| Session 13 (54 minutes) | Choosing Wisely: First, Doing No Harm | D. Weismiller, MD |
| Session 14 (57 minutes) | Management of Depression in Primary Care | D. Weismiller, MD |
Program Overview
Presented by Continuing Education Company (CEC) for the past 29 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recorded video lectures from recent conferences. The emphasis of this course is on practical and useful information for clinical practice.
This CME program will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This activity will highlight the latest science related to a variety of specialty areas, presented in a practical and patient-focused manner relevant to the primary care setting.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate.
Faculty
Kenneth Cusi, MD, FACP, FACE
Professor of Medicine
Staff, Malcom Randall VAMC
Chief, Division of Endocrinology, Diabetes and Metabolism
The University of Florida
Gainesville, FL
Nihar R. Desai, MD, MPH
Associate Professor of Medicine, Yale School of Medicine
Associate Chief, Section of Cardiovascular Medicine
Investigator, Center for Outcomes Research and Investigation
New Haven, CT
Deborah Bade Horn, DO, MPH. MFOMA
Medical Director at the UT Center for Obesity Medicine and Metabolic Performance
Assistant Professor, University of Texas McGovern Medical School, Dept of Surgery
Program Director, UT Allison Family Foundation Fellowship in Clinical Obesity
Medicine and Metabolic Performance
University of Texas McGovern School of Medicine
Houston, Texas
Scott Kaatz, DO, MSc, FACP, SFHM
Clinical Associate Professor
Wayne State University
Medical Director
Professional Development and Research
Division of Hospital Medicine
Hospitalist, Henry Ford Hospital
Detroit, MI
Deena E. Kuruvilla, MD, FAHS
Medical Director
Westport Headache Institute
Westport, CT
Kevin M. Pantalone, DO, ECNU, FACE
Staff Endocrinologist
Director of Diabetes Initiatives
Department of Endocrinology
Cleveland Clinic
Cleveland, OH
John H. Post III, MD
Orthopedic Surgeon
Martha Jefferson Hospital
Charlottesville, VA
Adam C. Stein, MD
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Charlie B. Strange, MD
Professor, Pulmonary & Critical Care Medicine
MUSC Health Medical University of South Carolina
Charleston, SC
Matthew R. Weir, MD
Professor of Medicine
Chief of Nephrology Division
University of Maryland School of Medicine
Baltimore, MD
David G. Weismiller, MD, ScM, FAAFP
Professor, Department of Family and Community Medicine
University of Nevada School of Medicine
Las Vegas, NV
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST complete the activity and the evaluation form. For ABIM MOC points, your information will be shared with the ABIM through the ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 7 of which can be used towards Pharmacology, for completing this activity.
Release Date: 7/13/2021
Expiration Date: 7/13/2024 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Sarah Lundquist-Galloway - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Kenneth Cusi, MD, FACP, FACE | Consultant: Allergan Pharmaceuticals, AstraZeneca, Coherus, Genentech, Gilead Sciences, Merck, and Pfizer Pharmaceuticals Advisory Board, Consultant: BMS Consultant, Grant Recipient: Cirius Therapeutics, Inc. Grant Recipient, Research Grant: Echosens and Zydus Consultant, Grant Recipient, Research Grant: Inventica, Janssen, Novartis Pharmaceuticals Corp., Novo Nordisk, and Poxel |
| Nihar R. Desai, MD, MPH | Advisory Board, Research Grant: Astra Zeneca Consultant: Amgen, Boehringer-Ingelheim, Cytokinetics, Novartis, Relypsa, and SCPharmaceuticals |
| Deborah Bade Horn, DO, MPH. MFOMA | Advisory Board: Gelesis Consultant: Currax and Medtronic Advisory Board, Consultant, Research Grant, Speakers Bureau: Novo Nordisk |
| Scott Kaatz, DO, MSc, FACP, SFHM | Board Membership: AC Forum, National Blood Clot Alliance Medical and Scientific Advisory Board and Thrombosis and Hemostasis Societies of North America Consultant: Bristol Myer Squibb, Pfizer, Portola, and Roche Consultant, Research Grant: Janssen |
| Deena E. Kuruvilla, MD, FAHS | Advisory Board, Consultant, Speakers Bureau: Allergan and Lilly Consultant, Speakers Bureau: Amgen Advisory Board, Associate Editor: Healthline Advisory Board, Consultant, Data Monitoring Committee: Theranica |
| Kevin M. Pantalone, DO, ECNU, FACE | Consultant, Speakers Bureau: Astra Zeneca Consultant: Bayer, Corcept Therapeutics, Eli Lilly, and Sanofi Advisory Board, Consultant, Research Grant, Speakers Bureau: Merck and Novo Nordisk |
| John H. Post III, MD | Nothing to Disclose |
| Adam C. Stein, MD | Advisory Board, Speakers Bureau: Abbvie Speakers Bureau: Alcresta and Pfizer |
| Charlie B. Strange, MD | Consultant, Research Grant: AstraZeneca, CSL Behring, and Grifols, Inc. Research Grant: CSA Medical, Matrx, and Nuvaira Consultant: GlaxoSmithKline and Uptake Medical Advisory Board, Research Grant: Vertex |
| Matthew R. Weir, MD | Advisory Board: Akebia, Astra, Bayer, Boehringer-Ingelheim, Boston Scientific, CareDx, Janssen, Lexicon, MSD, Relypsa, and Vifor Pharma Grant Recipient: National Institute of Diabetes and Digestive Kidney (NIDDK): R01DK 066013 Research Grant: NHLBI: R01HL127422, R01HL132732, U01DK106102, and U01DK116095 |
| David G. Weismiller, MD, ScM, FAAFP | Nothing to Disclose |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.